Dexamethasone-FITC staining application for measurement of circadian rhythmicity of glucocorticoid receptor expression in mouse living thymocyte subsets

Autor: Kowalik, Anna, Kiernozek, Ewelina, Kulinczak, Mariusz, Brodaczewska, Klaudia, Kozlowska, Ewa, Gieczewska, Katarzyna, Riccardi, Carlo, Drela, Nadzieja

Publikováno v: In Journal of Neuroimmunology 15 August 2013 261(1-2):44-52

Ni2+-Assisted Hydrolysis May Affect the Human Proteome; Filaggrin Degradation Ex Vivo as an Example of Possible Consequences

Autor: Podobas, Ewa Izabela, Gutowska-Owsiak, Danuta, Moretti, Sébastien, Poznański, Jarosław, Kulińczak, Mariusz, Grynberg, Marcin, Gruca, Aleksandra, Bonna, Arkadiusz, Płonka, Dawid, Ogg, Graham, Bal, Wojciech

Deficiency in a principal epidermal barrier protein, filaggrin (FLG), is associated with multiple allergic manifestations, including atopic dermatitis and contact allergy to nickel. Toxicity caused by dermal and respiratory exposures of the general p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e9d50ac37cf58753aff65e160e5668e

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Corrigendum: Ni ²⁺ -assisted hydrolysis may affect the human proteome; filaggrin degradation ex vivo as an example of possible consequences.

Autor: Podobas EI; Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.; Medical Research Council Human Immunology Unit, National Institute for Health Research Oxford Biomedical Research Centre, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Institute of Genetics and Biotechnology, University of Warsaw, Warsaw, Poland., Gutowska-Owsiak D; Medical Research Council Human Immunology Unit, National Institute for Health Research Oxford Biomedical Research Centre, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; University of Gdansk, Intercollegiate Faculty of Biotechnology of University of Gdańsk and Medical University of Gdańsk, Gdańsk, Poland., Moretti S; SIB Swiss Institute of Bioinformatics, Vital-IT Team, Lausanne, Switzerland., Poznański J; Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland., Kulińczak M; The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Grynberg M; Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland., Gruca A; Institute of Informatics, Faculty of Automatic Control, Electronics and Computer Science, Silesian University of Technology, Gliwice, Poland., Bonna A; Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom., Płonka D; Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland., Frączyk T; Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland., Ogg G; Medical Research Council Human Immunology Unit, National Institute for Health Research Oxford Biomedical Research Centre, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Bal W; Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.

Publikováno v: Frontiers in molecular biosciences [Front Mol Biosci] 2022 Dec 12; Vol. 9, pp. 1101224. Date of Electronic Publication: 2022 Dec 12 (Print Publication: 2022).